Skip To Main Content
Intended for US Payers

Rare blood disorders

Sanofi Market Access logo. Science. Innovation. Value.

Rare blood disorders R&D

One of the most robust rare blood disorder pipelines in the industry

Our research investigates:

Illustration representing small molecules.
Small molecules

Illustration representing messenger RNA.
RNA interference (RNAi)

Search for a specific clinical-stage project

Learn more

FDA-approved products in rare blood disorders

Our current portfolio includes approved treatments for:

Icon representing acquired thrombotic thrombocytopenic purport.

Acquired thrombotic
thrombocytopenic purpura

Product information

Icon representing cold agglutinin disease.

Cold agglutinin disease
 

Product information

Icon representing Hemophilia A.

Hemophilia A
 

Product information

Product information

Icon representing Hemophilia B.

Hemophilia B
 

Product information

Search for other FDA-approved products

Learn more

Explore our other areas of focus

Illustration of human immune cells with antibodies to represent the therapeutic area of immunology and inflammation.

Immunology and
inflammation

Learn more

Illustration of the human brain to represent the therapeutic area of neurology.

Neurology
 

Learn more

Illustration of a tumor to represent the therapeutic area of oncology.

Oncology
 

Learn more

Illustration of DNA strand to represent the therapeutic area of rare diseases.

Rare diseases
 

Learn more

Let’s connect

Schedule a meeting with a Sanofi Market Access team member to discuss how our therapies can bring value to your plan and members living with rare blood disorders.

Learn more

This site is intended for US payers only.
© 2024 Sanofi. All rights reserved.